liver damage

Pharma makers pull MS drug from worldwide marketIn a rare move, pharmaceutical manufacturers voluntarily recalled their drug to treat multiple sclerosis after reports of serious brain inflammation in patients.
Liver damage underestimated in hepatitis C patients
Liver damage underestimated in hepatitis C patientsClinical studies that rely on diagnostic codes or biopsies to provide evidence of cirrhosis may be underestimating the extent of the disease among hepatitis C patients, according to a new study.
FDA asks healthcare professionals to limit acetaminophen prescriptionsThe U.S. Food and Drug Administration (FDA) has asked healthcare professionals to stop prescribing combination prescription pain relievers that contain more than 325 mg of acetaminophen per tablet, capsule, or other dosage unit, citing the risk for liver damage.
FDA: Prescribers, dispensers should stop use of combination painkillers with more than 325 mg of acetaminophenFDA is recommending healthcare professionals discontinue prescribing and dispensing prescription combination drug products that contain more than 325 mg of acetaminophen per tablet, capsule or other dosage unit.
FDA limits use of tolvaptan; irreversible liver damage possibleFDA has issued a Drug Safety Communication indicating that the drug tolvaptan (Samsca, Otsuka American Pharmaceuticals), used in the treatment of electrolyte disturbances, can cause irreversible liver injury with the potential to result in liver transplant or death.